Tina Reinson

Transient elastography in patients at risk of liver fibrosis in primary care: a follow-up study over 54 months

C. Byrne, M. Moore, M. El-Gohary, 2021, BJGP open.

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future

C. Byrne, R. Buchanan, Tina Reinson, 2022, Clinical and molecular hepatology.

Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care

P. Roderick, B. Stuart, N. Sheron, 2018, PloS one.

Healthcare practitioners’ experiences of an intervention to detect and treat patients with liver disease (the LOCATE intervention): a qualitative process evaluation

N. Sheron, K. Bradbury, M. Moore, 2019, BMJ Open.

Performance of the Enhanced Liver Fibrosis Score, Comparison with Vibration-controlled Transient Elastography Data, and Development of a Simple Algorithm to Predict Significant Liver Fibrosis in a Community-based Liver Service: A Retrospective Evaluation

C. Byrne, R. Buchanan, J. Patel, 2023, Journal of clinical and translational hepatology.

Identification of individuals at risk of hepatocellular carcinoma: screening for clinically significant liver fibrosis in patients with T2DM

C. Byrne, R. Buchanan, Tina Reinson, 2023, Expert review of endocrinology & metabolism.